BB Biotech AG (HAM:BBZA) 3-Year Share Buyback Ratio : 0.30% (As of Mar. 2025)

View and export this data going back to 2008. Start your Free Trial

What is BB Biotech AG 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. BB Biotech AG's current 3-Year Share Buyback Ratio was 0.30%.

The historical rank and industry rank for BB Biotech AG's 3-Year Share Buyback Ratio or its related term are showing as below:

HAM:BBZA' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -69.9 Med: 5 Max: 48.3
Current: 0.3

During the past 13 years, BB Biotech AG's highest 3-Year Share Buyback Ratio was 48.30%. The lowest was -69.90%. And the median was 5.00%.

HAM:BBZA's 3-Year Share Buyback Ratio is ranked better than
94.96% of 1251 companies
in the Biotechnology industry
Industry Median: -9.8 vs HAM:BBZA: 0.30

Competitive Comparison of BB Biotech AG's 3-Year Share Buyback Ratio

For the Biotechnology subindustry, BB Biotech AG's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG's 3-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

BB Biotech AG 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

BB Biotech AG (HAM:BBZA) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

BB Biotech AG 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

BB Biotech AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (HAM:BBZA) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

BBZA:Germany BION:Switzerland

Address

Schwertstrasse 6, Schaffhausen, CHE, CH-8200

Website

https://www.bbbiotech.com

BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system.

BB Biotech AG Headlines

No Headlines